Edward J. Lee, P.C.

Prior to and since joining Kirkland, representative significant matters include the following:

• Genius Sports Group in its $1.5 billion business combination with dMY Technology Group, Inc. II
• United Technologies in the all-stock merger of equals of its Aerospace businesses with Raytheon Company
• Raytheon Technologies in its $1.925 billion divestiture of the Collins Aerospace military GPS business to BAE Systems
• Raytheon Technologies in its electro-optical solutions business to AMERGINT, a Blackstone portfolio company
• Expedia Group in its $1.2 billion private placement of preferred stock and warrants to investment funds managed by affiliates of Apollo Global Management, Inc. and Silver Lake
• Salesforce in its $15.7 billion acquisition of Tableau Software
• Publicis Groupe S.A. in its $4.4 billion acquisition of Alliance Data Systems’ Epsilon business
• Expedia Group in its all-stock acquisition of Liberty Expedia Holdings
• Celgene Corporation in its $98 billion acquisition by Bristol-Myers Squibb
• United Technologies in its three-way separation into Raytheon Technologies, Otis Worldwide and Carrier Global
• Michael Kors Holdings Limited in its €1.83 billion acquisition of Gianni Versace S.p.A.
• Frutarom Industries Ltd. in its $7.1 billion sale to International Flavors & Fragrances
• Salesforce in its $6.5 billion acquisition of MuleSoft
• United Technologies in its $30.3 billion acquisition of Rockwell Collins
• Mondelēz International in its acquisition of Tate’s Bake Shop
• United Technologies in the $1 billion sale of its Taylor Company business to The Middleby Corporation
• Colgate-Palmolive Company in its acquisitions of the EltaMD skin care brand and of the PCA Skin brand
• Prysmian Group in its $3 billion acquisition of General Cable
• Harman International Industries in its $8.8 billion acquisition by Samsung Electronics Co., Ltd.
• Regency Centers in its $15.6 billion merger with Equity One
• FMC Corporation in the acquisition of a significant portion of DuPont’s crop protection business and simultaneous sale to DuPont of FMC’s Health and Nutrition business
• Verizon Communications in its $4.83 billion acquisition of Yahoo!’s operating business
• Riverstone in its $5.2 billion acquisition of Talen Energy
• United Technologies in its $9 billion sale of Sikorsky Aircraft to Lockheed Martin
• Warburg Pincus and The Carlyle Group in their acquisition of DBRS Holdings Limited
• Publicis Groupe S.A. in its $3.7 billion acquisition of Sapient Corporation
• Tim Hortons Inc. in its $12.2 billion combination with Burger King Worldwide, Inc.
• Walgreens in its $27 billion two-staged acquisition of Alliance Boots GmbH
• Publicis Groupe S.A. in its $35.1 billion agreed combination with Omnicom
• The Wertheimer family and IMC International Metalworking Companies B.V. in Berkshire Hathaway’s $2.05 billion purchase from the Wertheimer family of the 20% stake in IMC it did not already own
• Thermo Fisher Scientific in its $13.6 billion acquisition of Life Technologies Corporation
• Walgreens in establishing a long-term partnership with AmerisourceBergen, including a 10-year distribution agreement, a global joint procurement agreement, and the right of Walgreens to acquire an equity interest in AmerisourceBergen through open market purchases and warrants
• SCBT Financial Corporation in its $300 million merger with First Financial Holdings and prior merger with Peoples Bancorporation, Inc.
• Goodrich Corporation in the sale of its pump and engine control systems business to the Triumph Group
• Goodrich Corporation in the sale of its electric power systems business to Safran S.A.
• Pacific Capital Bancorp in its $1.5 billion acquisition by UnionBanCal Corporation/The Bank of Tokyo-Mitsubishi UFJ
• United Technologies in its $18.4 billion acquisition of Goodrich Corporation
• Warburg Pincus in its acquisition of The Mutual Fund Store
• Goldman Sachs, Highstar Capital, The Carlyle Group and Riverstone Holdings in connection with their investments in Kinder Morgan, Inc. and Kinder Morgan’s $3.2 billion initial public offering
• Thermo Fisher Scientific in its $2.1 billion acquisition of Dionex
• Novartis AG in its acquisition of a majority stake in Alcon from Nestlé, and of Alcon’s public minority shares, in a transaction valued at $49.7 billion

Ed has also represented issuers in connection with many securities offerings and other capital raising transactions, totaling over $80 billion.